ko pathway ratio_in_study ratio_in_pop p_value ko00512 Mucin type O-glycan biosynthesis 6/93 29/7206 1.46892249679e-06 ko04210 Apoptosis 10/93 180/7206 9.8897591708e-05 ko04142 Lysosome 9/93 151/7206 0.00013172622394 ko04611 Platelet activation 9/93 163/7206 0.000235198259819 ko05100 Bacterial invasion of epithelial cells 7/93 99/7206 0.00026940501154 ko05146 Amoebiasis 7/93 99/7206 0.00026940501154 ko04726 Serotonergic synapse 8/93 137/7206 0.000363922289203 ko00590 Arachidonic acid metabolism 5/93 52/7206 0.000517419820633 ko00520 Amino sugar and nucleotide sugar metabolism 5/93 55/7206 0.000671825318797 ko00511 Other glycan degradation 3/93 26/7206 0.0043640415425 ko00603 Glycosphingolipid biosynthesis - globo and isoglobo series 2/93 8/7206 0.00438648857482 ko04750 Inflammatory mediator regulation of TRP channels 6/93 122/7206 0.00478489498341 ko05200 Pathways in cancer 14/93 492/7206 0.00530721432765 ko01523 Antifolate resistance 3/93 30/7206 0.00656602765744 ko04910 Insulin signaling pathway 7/93 172/7206 0.00660900979839 ko04217 Necroptosis 7/93 178/7206 0.00792874580391 ko05221 Acute myeloid leukemia 4/93 63/7206 0.00866872406593 ko04932 Non-alcoholic fatty liver disease (NAFLD) 7/93 182/7206 0.00891098849112 ko05152 Tuberculosis 7/93 187/7206 0.0102615395342 ko01521 EGFR tyrosine kinase inhibitor resistance 5/93 106/7206 0.011706387129 ko04623 Cytosolic DNA-sensing pathway 3/93 41/7206 0.0155719929299 ko04621 NOD-like receptor signaling pathway 6/93 157/7206 0.0156305402029 ko01524 Platinum drug resistance 4/93 76/7206 0.0164556498931 ko00513 Various types of N-glycan biosynthesis 3/93 42/7206 0.0166159751477 ko04668 TNF signaling pathway 5/93 120/7206 0.0191402627135 ko04666 Fc gamma R-mediated phagocytosis 5/93 122/7206 0.0204074178382 ko04211 Longevity regulating pathway 5/93 123/7206 0.0210611658998 ko05131 Shigellosis 4/93 82/7206 0.0211678892367 ko01522 Endocrine resistance 5/93 124/7206 0.021728493429 ko04215 Apoptosis - multiple species 3/93 47/7206 0.0224141224912 ko05220 Chronic myeloid leukemia 4/93 85/7206 0.0238046951484 ko05161 Hepatitis B 6/93 173/7206 0.0239939183786 ko00592 alpha-Linolenic acid metabolism 2/93 19/7206 0.0244335991642 ko05210 Colorectal cancer 4/93 86/7206 0.0247260228993 ko05142 Chagas disease (American trypanosomiasis) 5/93 130/7206 0.0260228414855 ko04931 Insulin resistance 5/93 137/7206 0.0316798107889 ko00591 Linoleic acid metabolism 2/93 22/7206 0.0321943434438 ko00531 Glycosaminoglycan degradation 2/93 23/7206 0.0349693507787 ko04650 Natural killer cell mediated cytotoxicity 4/93 97/7206 0.0362882643168 ko05132 Salmonella infection 4/93 98/7206 0.0374707575333 ko00261 Monobactam biosynthesis 1/93 3/7206 0.0382254335881 ko04620 Toll-like receptor signaling pathway 4/93 100/7206 0.0399019669803 ko04961 Endocrine and other factor-regulated calcium reabsorption 3/93 59/7206 0.0402631724193 ko04742 Taste transduction 3/93 61/7206 0.043769443864 ko04622 RIG-I-like receptor signaling pathway 3/93 62/7206 0.0455781711709 ko04913 Ovarian steroidogenesis 3/93 63/7206 0.0474236435263 ko04270 Vascular smooth muscle contraction 5/93 154/7206 0.048447368918